NCT00945425View on ClinicalTrials.gov

AZD7325 Japan Multiple Ascending Dose (MAD) Study

PHASE1TerminatedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 31, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy

Interventions

DRUG

AZD7325

oral capsule, once or twice daily, 7 days

DRUG

Placebo

oral capsule, once or twice daily, 7 days

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY